Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

aop orphan pharmaceuticals gmbh - tetrabenazine 25 mg - tablet - 25 mg - tetrabenazine 25 mg - tetrabenazine

Ireland - English - HPRA (Health Products Regulatory Authority)

aop orphan pharmaceuticals gmbh - tetrabenazine - tablet - 25 milligram(s) - other nervous system drugs; tetrabenazine

Ireland - English - HPRA (Health Products Regulatory Authority)

aop orphan pharmaceuticals gmbh - naltrexone hydrochloride - film-coated tablet - 50 milligram(s) - drugs used in alcohol dependence; naltrexone

Ireland - English - HPRA (Health Products Regulatory Authority)

aop orphan pharmaceuticals gmbh - naltrexone hydrochloride - film-coated tablet - 50 milligram(s) - drugs used in alcohol dependence; naltrexone

United States - English - NLM (National Library of Medicine)

hikma pharmaceuticals usa inc. - butorphanol tartrate (unii: 2l7i72ruhn) (butorphanol - unii:qv897jc36d) - butorphanol tartrate 1 mg in 1 ml - butorphanol tartrate injection is indicated: - as a preoperative or pre-anesthetic medication - as a supplement to balanced anesthesia - for the relief of pain during labor, and - for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. limitations of use because of the risks of addiction, abuse, and misuse, with opioids, even at recommended doses [see warnings ], reserve butorphanol tartrate injection for use in patients for whom alternative treatment options [e.g. non-opioid analgesics] - have not been tolerated, or are not expected to be tolerated - have not provided adequate analgesia, or are not expected to provide adequate analgesia butorphanol tartrate injection is contraindicated in: - patients with significant respiratory depression [see warnings ] - patients with acute or severe bronchial asthma in an unmonitored setting or in the absence of resuscitative equipment [see warnings ] - patients with known or suspected gastrointestinal

Israel - English - Ministry of Health

aop orphan pharmaceuticals israel ltd, israel - nabilone - capsules - nabilone 1 mg - nabilone - canemes is indicated for the treatment of chemotherapy-induced vomiting and nausea in adult cancer patients, who do not respond adequately to other antiemetic treatments

Israel - English - Ministry of Health

aop orphan pharmaceuticals israel ltd, israel - nabilone - capsules - nabilone 1 mg - nabilone - canemes is indicated for the treatment of chemotherapy-induced vomiting and nausea in adult cancer patients, who do not respond adequately to other antiemetic treatments

Israel - English - Ministry of Health

aop orphan pharmaceuticals israel ltd, israel - nabilone - capsules - nabilone 1 mg - nabilone - canemes is indicated for the treatment of chemotherapy-induced vomiting and nausea in adult cancer patients, who do not respond adequately to other antiemetic treatments

Israel - English - Ministry of Health

aop orphan pharmaceuticals israel ltd, israel - esmolol hydrochloride - solution for injection - esmolol hydrochloride 10 mg/ml - esmolol - esmolol amomed 100 mg/10 ml is indicated for supraventricular tachycardia (except for pre-excitation syndromes) and for the rapid control of the ventricular rate in adult patients with atrial fibrillation or atrial flutter in perioperative, postoperative, or other circumstances where short-term control of the ventricular rate with a short-acting agent is desirable.esmolol amomed 100 mg/10 ml is also indicated for tachycardia and hypertension occurring in the perioperative phase and non-compensatory sinus tachycardia in adult patients where, in the physician’s judgement the rapid heart rate requires specific intervention.esmolol amomed 100 mg/10 ml is not intended for use in chronic settings.

European Union - English - EMA (European Medicines Agency)

aop orphan pharmaceuticals gmbh - ropeginterferon alfa-2b - polycythemia vera - immunostimulants, - besremi is indicated as monotherapy in adults for the treatment of polycythaemia vera without symptomatic splenomegaly.